| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.06 |